{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:05:13Z","timestamp":1753891513948,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>We report a rare case of pulmonary mucormycosis caused by <jats:italic>Rhizopus microsporus<\/jats:italic>, which is rare in patients with chronic obstructive pulmonary disease. <jats:italic>Rhizopus microsporus<\/jats:italic> had been reported as the most common etiological agent associated with human infections, except <jats:italic>Rhizopus oryzae<\/jats:italic> in some studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We described a case of 81-year-old man with pulmonary mucormycosis caused by <jats:italic>Rhizopus microsporus<\/jats:italic> but no other apparent risk factors including diabetes. The diagnosis mainly relied on sputum cultures and clinical manifestations. Despite antifungal therapy, his condition worsened, resulting in mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this case, the patient had no underlying diseases such as diabetes or solid tumors. Clinicians should be aware of routine pathogenic microbiological tests of pulmonary mucormycosis in patients with chronic obstructive pulmonary disease. Early and aggressive treatment can lead to improved prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1544621","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:10:13Z","timestamp":1744171813000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Pulmonary mucormycosis caused by Rhizopus microsporus in a patient with chronic obstructive pulmonary disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Shanshan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12185-012-1210-y","article-title":"Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies","volume":"96","author":"Kurosawa","year":"2012","journal-title":"Int J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"E121","DOI":"10.21037\/jtd.2017.02.31","article-title":"Chronic pulmonary mucormycosis: an emerging fungal infection in diabetes mellitus","volume":"9","author":"Iqbal","year":"2017","journal-title":"J Thorac Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1164\/rccm.202307-1125IM","article-title":"Pulmonary artery pseudoaneurysm caused by pulmonary mucormycosis","volume":"209","author":"Zhang","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"volume-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, approved standard M38-A2","year":"2008","author":"Rex","key":"ref5"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mmcr.2014.08.001","article-title":"Multifocal Rhizopus microsporus lung infection following brush clearing","volume":"6","author":"Tsyrkunou","year":"2014","journal-title":"Med Mycol Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/j.1440-1843.2009.01615.x","article-title":"Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease","volume":"14","author":"Tsimogianni","year":"2009","journal-title":"Respirology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e00128","DOI":"10.1128\/JCM.00128-20","article-title":"Multicenter evaluation of the BioFire FilmArray pneumonia\/pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection","volume":"58","author":"Murphy","year":"2020","journal-title":"J Clin Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/jof5040106","article-title":"Updates on the taxonomy of Mucorales with an emphasis on clinically important taxa","volume":"5","author":"Walther","year":"2019","journal-title":"J Fungi"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1469-0691.2009.02988.x","article-title":"Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?","volume":"15","author":"Pongas","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1159\/000066467","article-title":"Pulmonary mucormycosis in the setting of chronic obstructive pulmonary disease","volume":"69","author":"Spira","year":"2002","journal-title":"Respiration"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/myc.13256","article-title":"The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis","volume":"64","author":"Ahmadikia","year":"2021","journal-title":"Mycoses"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1093\/cid\/cit094","article-title":"Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients","volume":"56","author":"Millon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1128\/JCM.00908-09","article-title":"Outbreak of intestinal infection due to Rhizopus microsporus","volume":"47","author":"Cheng","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3201\/eid1710.110087","article-title":"Invasive non-aspergillus mold infections in transplant recipients, United States, 2001\u20132006","volume":"17","author":"Park","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1517\/14656566.2015.1057500","article-title":"The \u2018cephalosporin era\u2019 of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections","volume":"16","author":"Chitasombat","year":"2015","journal-title":"Expert Opin Pharmacother"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1544621\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:10:15Z","timestamp":1744171815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1544621\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":19,"alternative-id":["10.3389\/fmed.2025.1544621"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1544621","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"article-number":"1544621"}}